Indefinite Delivery Contract SPE2D225D0008

Award Date 3/4/25
Last Date to Order 3/3/30
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2D219D0065 was awarded to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products based in Camarillo, California. The contract, awarded by the Defense Logistics Agency Troop Support Medical, has a ceiling value of $8,768,654.55 and a period of performance extending to April 8, 2024. The contract aims to establish a national supply source for Enalapril Maleate tablets in various dosages and...
The Indefinite Delivery Contract (IDC) SPE2D223D0012 was awarded by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The contract has a ceiling value of $4,329,877.25 and a period of performance ending on October 17, 2028. Under this IDC, Golden State Medical Supply provides a diverse array of pharmaceutical products, including medications used to treat conditions such as heartburn,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Golden State Medical Supply, Inc. (GSMS), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract has a ceiling value of $4,547,341.50 and a period of performance ending on May 23, 2026. The IDC facilitates the provision of a wide range of pharmaceutical products to the Department of Defense (DoD), Department of Veterans Affairs (VA),...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical products. The $9.7 million single-award IDC (contract number SPE2D220D0091) has an ultimate completion date of April 28, 2025. The contract enables the Department of Defense (DoD), Department of Veterans Affairs (VA), Bureau of Prisons, and Indian Health Service (IHS) to place delivery orders against...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The $3,719,687.18 IDC has an ultimate completion date of July 9, 2029 and enables the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service (IHS) to place delivery orders for a wide range of pharmaceutical products. The IDC...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract has a potential value of $2,693,678.00 and a period of performance through January 7, 2025. The contract enables Golden State Medical Supply to provide a wide range of pharmaceutical products on an as-needed basis to meet the medication requirements of the...
This indefinite delivery contract (IDC) award, SPE2D222D0141, was made by the Defense Logistics Agency (DLA) to the prime contractor Golden State Medical Supply, Inc. (GSMS). The contract has a ceiling value of $24,393,556.55 and a period of performance through January 25, 2027. Under this IDC, GSMS, a for-profit manufacturer and distributor of pharmaceuticals, will provide a wide range of pharmaceutical products to various federal agencies, including the Department of Veterans Affairs (VA),...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract has a ceiling value of $7,779,829.50 and a period of performance from October 7, 2021 to October 6, 2025, including a base year and four one-year option periods. The contract covers the supply of four line items for Diltiazem capsules, a medication used to treat...
The key products and services being delivered under this federal contract IDV award are pharmaceutical products, primarily prescription medications, to various government healthcare agencies and facilities. The prime contractor, Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of medical supplies based in Camarillo, California, has been awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency Troop Support Medical, a component of the...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...

This Indefinite Delivery Contract (IDC) award, SPE2D225D0008, was issued by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $6,265,543.94 and a period of performance running through March 3, 2030.

The IDC serves as a national requirements contract vehicle to provide Enalapril Maleate tablets in various dosages and package sizes to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. The contract was awarded as a firm-fixed price commercial item acquisition with a one-year base period and four one-year option periods. The original solicitation outlined the specific tablet strengths, package sizes, and estimated annual usage, though the agency reserved the right to modify the solicitation details prior to issuance. This unrestricted and fully competitive acquisition does not utilize any small business set-asides.

Generated 6/3/25, 9:56 AM